Dec 2014 $4 M No. 5 $2 to $10 million 14
Biogenic Reagents, LLC: Raise no. 5, Dec 2014 × Investors in this round 14 investors had bought by the notice of Jan 23, 2015: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $300,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Limited Liability Company, incorporated in Delaware People named in the notice Daniel A Despen · Executive Officer, Director Douglas A Rohall · Executive Officer, Director James A Mennell · Executive Officer, Director, Promoter Enrico A Biasetti · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James A. Mennell, Ceo. Source: SEC Form D, newest notice filed Jan 23, 2015. Read the notice at the SEC .
equity, options SEC Jul 2013 $10 M No. 4 $2 to $10 million 1
Biogenic Reagents, LLC: Raise no. 4, Jul 2013 × Investors in this round 1 investor had bought by the notice of Jul 25, 2013: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken no minimum stated
What was sold equity, debt
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Limited Liability Company, incorporated in Delaware People named in the notice Daniel A Despen · Executive Officer, Director David A Reamer · Executive Officer Douglas A Rohall · Executive Officer, Director James A Mennell · Executive Officer, Director, Promoter Enrico A Biasetti · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James A. Mennell, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 25, 2013. Read the notice at the SEC .
equity, debt SEC Mar 2013 $2 M No. 3 $2 to $10 million 18
Biogenic Reagents, LLC: Raise no. 3, Mar 2013 × Investors in this round 18 investors had bought by the notice of Apr 5, 2013: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $5 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Limited Liability Company, incorporated in Delaware People named in the notice Daniel Despen · Executive Officer, Director David Reamer · Executive Officer Douglas Rohall · Executive Officer, Director James Mennell · Executive Officer, Director, Promoter Enrico Biasetti · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James A. Mennell, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 5, 2013. Read the notice at the SEC .
equity SEC Dec 2011 $7 M No. 2 $2 to $10 million 33
Biogenic Reagents, LLC: Raise no. 2, Dec 2011 × Investors in this round 33 investors had bought by the notice of Nov 20, 2012: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $800,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Limited Liability Company, incorporated in Delaware People named in the notice Daniel A Despen · Executive Officer, Director David A Reamer · Executive Officer Douglas A Rohall · Executive Officer, Director James A Mennell · Executive Officer, Director, Promoter Enrico A Biasetti · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James A. Mennell, Ceo. Source: SEC Form D and 2 amendments, newest notice filed Nov 20, 2012. Read the notice at the SEC .
equity SEC Feb 2011 $6 M No. 1 $2 to $10 million 16
Biogenic Reagents, LLC: Raise no. 1, Feb 2011 × Investors in this round 16 investors had bought by the notice of Mar 8, 2011: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people $1,000,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Limited Liability Company, incorporated in Delaware People named in the notice Daniel A Despen · Executive Officer, Director David A Reamer · Executive Officer, Director James A Mennell · Executive Officer, Director, Promoter John S Watson · Executive Officer Enrico A Biasetti · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James A Mennell, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 8, 2011. Read the notice at the SEC .
equity SEC